- ThatThe FDA has granted 510(k) clearancetoBrainsWay Ltd(NASDAQ: BWAY) H7 deep transcranial magnetic stimulation (TMS) coil for use in the treatment of adults suffering from major depressive disorder and depression, including those with co-morbid anxiety symptoms commonly known as anxious depression.
- The FDA’s approval was based on their review of…
Full story available at Benzinga.com
[ad_2]
Source story